PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Wednesday reported a loss of $102.6 million in its second quarter.

The Palo Alto, California-based company said it had a loss of 84 cents per share. Losses, adjusted for stock option expense and non-recurring costs, were 48 cents per share.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The provider of oncology testing services posted revenue of $177.2 million in the period, also exceeding Street forecasts. Nine analysts surveyed by Zacks expected $161.9 million.

Guardant Health expects full-year revenue in the range of $690 million to $700 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH